These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio. Navab M; Hama-Levy S; Van Lenten BJ; Fonarow GC; Cardinez CJ; Castellani LW; Brennan ML; Lusis AJ; Fogelman AM; La Du BN J Clin Invest; 1997 Apr; 99(8):2005-19. PubMed ID: 9109446 [TBL] [Abstract][Full Text] [Related]
4. An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice. Navab M; Anantharamaiah GM; Reddy ST; Van Lenten BJ; Wagner AC; Hama S; Hough G; Bachini E; Garber DW; Mishra VK; Palgunachari MN; Fogelman AM Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1932-7. PubMed ID: 15961700 [TBL] [Abstract][Full Text] [Related]
5. Ambient ultrafine particles alter lipid metabolism and HDL anti-oxidant capacity in LDLR-null mice. Li R; Navab M; Pakbin P; Ning Z; Navab K; Hough G; Morgan TE; Finch CE; Araujo JA; Fogelman AM; Sioutas C; Hsiai T J Lipid Res; 2013 Jun; 54(6):1608-1615. PubMed ID: 23564731 [TBL] [Abstract][Full Text] [Related]
6. Procollagen C-endopeptidase Enhancer Protein 2 (PCPE2) Reduces Atherosclerosis in Mice by Enhancing Scavenger Receptor Class B1 (SR-BI)-mediated High-density Lipoprotein (HDL)-Cholesteryl Ester Uptake. Pollard RD; Blesso CN; Zabalawi M; Fulp B; Gerelus M; Zhu X; Lyons EW; Nuradin N; Francone OL; Li XA; Sahoo D; Thomas MJ; Sorci-Thomas MG J Biol Chem; 2015 Jun; 290(25):15496-15511. PubMed ID: 25947382 [TBL] [Abstract][Full Text] [Related]
7. Cholesterol reduction and atherosclerosis inhibition by bezafibrate in low-density lipoprotein receptor knockout mice. Inaba T; Yagyu H; Itabashi N; Tazoe F; Fujita N; Nagashima S; Okada K; Okazaki M; Furukawa Y; Ishibashi S Hypertens Res; 2008 May; 31(5):999-1005. PubMed ID: 18712055 [TBL] [Abstract][Full Text] [Related]
8. Regression and stabilization of advanced murine atherosclerotic lesions: a comparison of LDL lowering and HDL raising gene transfer strategies. Van Craeyveld E; Gordts SC; Nefyodova E; Jacobs F; De Geest B J Mol Med (Berl); 2011 Jun; 89(6):555-67. PubMed ID: 21249329 [TBL] [Abstract][Full Text] [Related]
9. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis. Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499 [TBL] [Abstract][Full Text] [Related]
10. A new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosis. Garber DW; Datta G; Chaddha M; Palgunachari MN; Hama SY; Navab M; Fogelman AM; Segrest JP; Anantharamaiah GM J Lipid Res; 2001 Apr; 42(4):545-52. PubMed ID: 11290826 [TBL] [Abstract][Full Text] [Related]
11. Analysis of low-density lipoprotein catabolism by primary cultures of hepatic cells from normal and low-density lipoprotein receptor knockout mice. Truong TQ; Auger A; Denizeau F; Brissette L Biochim Biophys Acta; 2000 Apr; 1484(2-3):307-15. PubMed ID: 10760479 [TBL] [Abstract][Full Text] [Related]
12. Low and high density lipoprotein metabolism in primary cultures of hepatic cells from normal and apolipoprotein E knockout mice. Auger A; Truong TQ; Rhainds D; Lapointe J; Letarte F; Brissette L Eur J Biochem; 2001 Apr; 268(8):2322-30. PubMed ID: 11298750 [TBL] [Abstract][Full Text] [Related]
13. Deficiency of circadian gene cryptochromes in bone marrow-derived cells protects against atherosclerosis in LDLR Lin YS; Tsai ML; Hsieh IC; Wen MS; Wang CY FASEB J; 2021 Feb; 35(2):e21309. PubMed ID: 33423309 [TBL] [Abstract][Full Text] [Related]
14. Sphingosine-1-Phosphate Receptor 1, Expressed in Myeloid Cells, Slows Diet-Induced Atherosclerosis and Protects against Macrophage Apoptosis in Ldlr KO Mice. Gonzalez L; Qian AS; Tahir U; Yu P; Trigatti BL Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29244772 [TBL] [Abstract][Full Text] [Related]
15. Combination therapy with cilostazol and pravastatin improves antiatherogenic effects in low-density lipoprotein receptor knockout mice. Park KY; Heo TH Cardiovasc Ther; 2018 Dec; 36(6):e12476. PubMed ID: 30378752 [TBL] [Abstract][Full Text] [Related]
16. Hyodeoxycholic acid improves HDL function and inhibits atherosclerotic lesion formation in LDLR-knockout mice. Shih DM; Shaposhnik Z; Meng Y; Rosales M; Wang X; Wu J; Ratiner B; Zadini F; Zadini G; Lusis AJ FASEB J; 2013 Sep; 27(9):3805-17. PubMed ID: 23752203 [TBL] [Abstract][Full Text] [Related]